18-Jun-2026
Biggest stock movers Thursday: INTC, KR, ACN, and more
Seeking Alpha News (Thu, 18-Jun 10:14 AM ET)
Why Is Legend Biotech Stock Falling Thursday?
Benzinga (Thu, 18-Jun 8:27 AM ET)
Benzinga (Thu, 18-Jun 6:10 AM ET)
Biggest stock movers Thursday: INTC, RUM, SPRO and more
Seeking Alpha News (Thu, 18-Jun 6:02 AM ET)
Legend Biotech shares slide post-pricing of $226M public offering at $29.35 per unit
Seeking Alpha News (Thu, 18-Jun 1:57 AM ET)
Legend Biotech Corporation Announces Pricing of Public Offering
Globe Newswire (Wed, 17-Jun 9:21 PM ET)
Legend Biotech launches $225M ADS public offering; shares down
Seeking Alpha News (Wed, 17-Jun 4:50 PM ET)
Legend Biotech Corporation Announces Proposed Public Offering
Globe Newswire (Wed, 17-Jun 4:29 PM ET)
Globe Newswire (Sun, 14-Jun 3:15 AM ET)
Globe Newswire (Tue, 2-Jun 9:30 AM ET)
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Legend Biotech - American Depositary Shares trades on the NASDAQ stock market under the symbol LEGN.
As of June 18, 2026, LEGN stock price declined to $27.93 with 12,163,580 million shares trading.
LEGN has a beta of 1.29, meaning it tends to be more sensitive to market movements. LEGN has a correlation of 0.06 to the broad based SPY ETF.
LEGN has a market cap of $5.12 billion. This is considered a Mid Cap stock.
Last quarter Legend Biotech - American Depositary Shares reported $305 million in Revenue and -$.03 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.11.
In the last 3 years, LEGN traded as high as $77.32 and as low as $16.24.
The top ETF exchange traded funds that LEGN belongs to (by Net Assets): IBB, IEMG, CANC, PBE, MCHI.
LEGN has underperformed the market in the last year with a price return of -19.9% while the SPY ETF gained +26.9%. However, in the short term, LEGN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +53.4% vs +13.5% return in SPY. But in the last 2 weeks, LEGN shares have been beat by the market, returning -18.3% compared to an SPY return of -1.1%.
LEGN support price is $31.93 and resistance is $35.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LEGN shares will trade within this expected range on the day.